BusinessProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery systemBy Nasdaq OMXApr 3, 2018, 1:02 PM UTC
BusinessProLynx announces SBIR grant award to develop novel technology for dual receptor agonistsBy Nasdaq OMXSep 25, 2017, 1:00 PM UTC
